Thomas Gonwa

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint The challenges of providing renal replacement therapy in decompensated liver cirrhosis
    Thomas A Gonwa
    Department of Transplantation, Mayo Clinic in Florida, Jacksonville, FL 32224, USA
    Blood Purif 33:144-8. 2012
  2. doi request reprint Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database
    Thomas A Gonwa
    Department of Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA
    Transplantation 92:31-5. 2011
  3. ncbi request reprint Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?
    T A Gonwa
    Department of Transplantation, Mayo Clinic Jacksonville, Jacksonville, Florida, USA
    Am J Transplant 6:2651-9. 2006
  4. ncbi request reprint Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations
    Thomas A Gonwa
    Department of Transplantation, Mayo Clinic, Jacksonville, FL 32216, USA
    Liver Transpl 10:301-9. 2004
  5. ncbi request reprint Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months
    Thomas Gonwa
    Mayo Clinic, Jacksonville, FL 32216, USA
    Transplantation 75:1213-20. 2003
  6. ncbi request reprint Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination
    Thomas A Gonwa
    Baylor University Medical Center, Dallas, TX, USA
    Transplantation 74:1560-7. 2002
  7. ncbi request reprint Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody
    Thomas A Gonwa
    Baylor Institute of Transplantation Sciences, Baylor University Medical Center, Dallas, Texas, USA
    Clin Transplant 16:144-9. 2002
  8. ncbi request reprint End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment
    T A Gonwa
    Baylor Institute for Transplant Sciences, Baylor University Medical Center, Dallas, Texas, USA
    Transplantation 72:1934-9. 2001
  9. ncbi request reprint Hypertension and renal dysfunction in long-term liver transplant recipients
    T A Gonwa
    Renal and Pancreas Transplant, Mayo Clinic Transplant Center, Jacksonville, FL 32216, USA
    Liver Transpl 7:S22-6. 2001
  10. ncbi request reprint Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years
    Thomas Gonwa
    Mayo Clinic Transplant Center, 4205 Belfort Blvd, Suite 1100, Jacksonville, FL, 32216, USA
    Transplantation 75:2048-53. 2003

Detail Information

Publications31

  1. doi request reprint The challenges of providing renal replacement therapy in decompensated liver cirrhosis
    Thomas A Gonwa
    Department of Transplantation, Mayo Clinic in Florida, Jacksonville, FL 32224, USA
    Blood Purif 33:144-8. 2012
    ..These are still considered experimental, although the MARS system has been utilized to treat patients with hepatorenal syndrome, and is available outside the United States...
  2. doi request reprint Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database
    Thomas A Gonwa
    Department of Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA
    Transplantation 92:31-5. 2011
    ..Patients after liver transplant have a high incidence of chronic kidney disease and end-stage renal disease (ESRD). We investigated kidney transplantation after liver transplantation using the Organ Procurement Transplant Network database...
  3. ncbi request reprint Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?
    T A Gonwa
    Department of Transplantation, Mayo Clinic Jacksonville, Jacksonville, Florida, USA
    Am J Transplant 6:2651-9. 2006
    ..Despite this, patient survival following orthotopic liver transplant (OLTX) in the 34 months after introduction of MELD is not different than prior to introduction of MELD...
  4. ncbi request reprint Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations
    Thomas A Gonwa
    Department of Transplantation, Mayo Clinic, Jacksonville, FL 32216, USA
    Liver Transpl 10:301-9. 2004
    ..Better methods for estimating the GFR are required for evaluation of renal function before and after liver transplantation...
  5. ncbi request reprint Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months
    Thomas Gonwa
    Mayo Clinic, Jacksonville, FL 32216, USA
    Transplantation 75:1213-20. 2003
    ..Results at 6 months of follow-up are presented...
  6. ncbi request reprint Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination
    Thomas A Gonwa
    Baylor University Medical Center, Dallas, TX, USA
    Transplantation 74:1560-7. 2002
    ..This study evaluated whether renal function could be improved by elimination of CsA from an SRL-based regimen...
  7. ncbi request reprint Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody
    Thomas A Gonwa
    Baylor Institute of Transplantation Sciences, Baylor University Medical Center, Dallas, Texas, USA
    Clin Transplant 16:144-9. 2002
    ..The purpose of this study was to evaluate the efficacy of the anti-CD25 monoclonal antibody basiliximab (BSLIX) started post-operatively in patients at high risk for DGF combined with low dose tacrolimus (TAC)...
  8. ncbi request reprint End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment
    T A Gonwa
    Baylor Institute for Transplant Sciences, Baylor University Medical Center, Dallas, Texas, USA
    Transplantation 72:1934-9. 2001
    ..This retrospective study examines the incidence and treatment of ESRD and chronic renal failure (CRF) in OLTX patients...
  9. ncbi request reprint Hypertension and renal dysfunction in long-term liver transplant recipients
    T A Gonwa
    Renal and Pancreas Transplant, Mayo Clinic Transplant Center, Jacksonville, FL 32216, USA
    Liver Transpl 7:S22-6. 2001
    ..4. Hypertension occurs in greater than 50% of long-term survivors. 5. Immunosuppressive protocols must be adjusted early to avoid long-term complications...
  10. ncbi request reprint Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years
    Thomas Gonwa
    Mayo Clinic Transplant Center, 4205 Belfort Blvd, Suite 1100, Jacksonville, FL, 32216, USA
    Transplantation 75:2048-53. 2003
    ..All regimens contained corticosteroids, and antibody induction was used only in patients who experienced delayed graft function (DGF). Patients were followed-up for 3 years...
  11. doi request reprint Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy
    H M Wadei
    Department of Transplantation, Mayo Clinic and Foundation, Jacksonville, FL, USA
    Am J Transplant 8:2618-26. 2008
    ..Randomized studies are needed to determine if PRB can direct kidney allocation in this challenging group of liver transplant candidates...
  12. ncbi request reprint Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis
    T A Gonwa
    Baylor Institute of Transplant Sciences, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75204, USA
    Transplantation 71:1424-8. 2001
    ..We have examined our patient population to determine the effect of necessity and type of RRT on patient survival after OLTX...
  13. ncbi request reprint Readmission to the intensive care unit after liver transplantation
    M F Levy
    Department of Transplant Services, Baylor University Medical Center, Dallas, TX 75246 2096, USA
    Crit Care Med 29:18-24. 2001
    ..Patients who, after liver transplantation, fail discharge from the Intensive Care Unit (ICU) and must be readmitted to that unit may well utilize many more resources than those patients who are well enough to stay out of the ICU...
  14. ncbi request reprint The long-term management of pancreas transplantation
    Martin L Mai
    Department of Transplantation, Mayo Clinic, Jacksonville, FL 32216, USA
    Transplantation 82:991-1003. 2006
    ..3 million accounting for 60% of ESRD population. To date, DM is the leading indication for transplantation and is the cause of ESRD in more than 40% of all transplant recipients each year...
  15. pmc The elderly liver transplant recipient: a call for caution
    M F Levy
    Baylor University Medical Center, Transplantation Services, Dallas, Texas 75246, USA
    Ann Surg 233:107-13. 2001
    ..To determine whether liver transplantation is judicious in recipients older than 60 years of age...
  16. ncbi request reprint Transplantation
    T A Gonwa
    Transplant Services, Baylor University Medical Center, Dallas, TX 75246, USA
    Am J Kidney Dis 35:S153-9. 2000
    ..This paper reviews the major ethical and social problems that still need to be addressed in regards to transplantation. These include organ supply, organ distribution, access to care, funding, and xenotransplantation...
  17. ncbi request reprint Cannulation of the aorta in organ donors with infrarenal aortic pathologies
    E P Molmenti
    Baylor University Medical Center, Dallas, Texas 75246, USA
    Dig Dis Sci 46:2457-9. 2001
    ..This technique allows for perfusion with UW solution without having to cannulate through severely atherosclerotic distal aortic walls...
  18. ncbi request reprint Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus
    M F Levy
    Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246, USA
    Transplantation 69:272-80. 2000
    ..Whole organ extracorporeal perfusion of a genetically modified humanized (transgenic) pig liver has been proposed as a technology that may sustain patients with severe liver failure while awaiting human liver transplantation...
  19. doi request reprint Polymicrobial seminal vesical abscess in a kidney transplant recipient
    Hani M Wadei
    Department of Transplantation, Mayo Clinic College of Medicine, Jacksonville, Florida 32216, USA
    Urology 72:296. 2008
    ..Here we report a polymicrobial seminal vesicle abscess in a kidney transplant recipient that was not associated with any of the known precipitating events...
  20. ncbi request reprint Review of major clinical trials with mycophenolate mofetil in renal transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, Lillian Jean Kaplan Renal Transplant Center, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33101, USA
    Transplantation 80:S191-200. 2005
    ....
  21. ncbi request reprint Chronic renal failure after transplantation of a nonrenal organ
    Thomas A Gonwa
    N Engl J Med 349:2563-5; author reply 2563-5. 2003
  22. ncbi request reprint Identification of patients best suited for combined liver-kidney transplantation: part II
    Connie L Davis
    Department of Medicine, Division of Nephrology, University of Washington, Seattle, WA 98195, USA
    Liver Transpl 8:193-211. 2002
    ....
  23. ncbi request reprint De novo tumors after liver transplantation: a single-institution experience
    Edmund Q Sanchez
    Transplantation Services, Baylor University Medical Center, Dallas, TX 75246, USA
    Liver Transpl 8:285-91. 2002
    ..The risk for development was not enough to preclude transplantation. We found that tumors developed in chronological fashion. Therefore, directed surveillance, patient education, and early detection may facilitate earlier treatment...
  24. ncbi request reprint Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients
    Ernesto P Molmenti
    Transplantation Services, Baylor University Medical Center, Dallas, TX 75246, USA
    Liver Transpl 8:519-26. 2002
    ..We cannot establish with certainty whether the observed process represents recurrence of the original autoimmune disease, an alloimmune phenomenon, or allograft dysfunction mimicking AIH...
  25. ncbi request reprint Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study
    Barry D Kahan
    Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX, USA
    Transplantation 76:1079-84. 2003
    ..This study examined the safety, pharmacodynamics, and pharmacokinetics of multiple doses of FTY720 in stable renal transplant patients...
  26. ncbi request reprint Combined kidney liver transplant in the MELD era: where are we going?
    Thomas A Gonwa
    Liver Transpl 11:1022-5. 2005
  27. ncbi request reprint Hepatorenal syndrome: pathophysiology and management
    Hani M Wadei
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Jacksonville, FL 32216, USA
    Clin J Am Soc Nephrol 1:1066-79. 2006
  28. ncbi request reprint Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation
    Edmund Q Sanchez
    Baylor Regional Transplant Institute, Dallas, Texas 75204, USA
    Transplantation 78:1048-54. 2004
    ..Our center has previously reported a 1-year survival of only 41.8%. We undertook this study to determine whether we could identify preoperative and perioperative factors that would predict which patients are at risk...
  29. ncbi request reprint Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation
    Ernesto P Molmenti
    Transplantation Services, Baylor University Medical Center, Dallas, TX 75246, USA
    Liver Transpl 8:160-3. 2002
    ..In our series, there was a 6.2% incidence of postoperative HASs. We observed a significant association between intraoperative hepatic artery and portal vein flows and postoperative HASs...
  30. ncbi request reprint Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I
    Connie L Davis
    Department of Medicine, Division of Nephrology, University of Washington, Seattle, WA 98195, USA
    Liver Transpl 8:91-109. 2002
    ....
  31. pmc Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation
    Ernesto P Molmenti
    Baylor University Medical Center, Dallas, Texas 75246, USA
    Ann Surg 235:292-6. 2002
    ..To determine the efficacy of portal thrombendvenectomy in cases of portal vein thrombosis at the time of orthotopic liver transplantation...